Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 1
1954 1
1955 2
1956 1
1958 2
1961 2
1963 2
1964 2
1965 1
1966 2
1967 2
1968 1
1969 1
1970 5
1971 5
1972 1
1973 4
1974 1
1975 4
1976 3
1977 3
1978 4
1979 4
1980 4
1981 6
1982 7
1983 2
1984 7
1985 3
1986 10
1987 14
1988 13
1989 13
1990 19
1991 11
1992 23
1993 26
1994 22
1995 30
1996 30
1997 51
1998 65
1999 65
2000 85
2001 105
2002 138
2003 168
2004 208
2005 193
2006 279
2007 322
2008 399
2009 452
2010 536
2011 665
2012 804
2013 840
2014 883
2015 986
2016 990
2017 1030
2018 1033
2019 1053
2020 1194
2021 1247
2022 1135
2023 920
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

14,298 results

Results by year

Filters applied: . Clear all
Page 1
Catechol-Amyloid Interactions.
Le NTK, Kang EJ, Park JH, Kang K. Le NTK, et al. Among authors: park jh. Chembiochem. 2023 Oct 18:e202300628. doi: 10.1002/cbic.202300628. Online ahead of print. Chembiochem. 2023. PMID: 37850717 Review.
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, Marasa M, Zhang JY, Balderes O, Sanna-Cherchi S, Bomback AS, Canetta PA, Appel GB, Radhakrishnan J, Trimarchi H, Sprangers B, Cattran DC, Reich H, Pei Y, Ravani P, Galesic K, Maixnerova D, Tesar V, Stengel B, Metzger M, Canaud G, Maillard N, Berthoux F, Berthelot L, Pillebout E, Monteiro R, Nelson R, Wyatt RJ, Smoyer W, Mahan J, Samhar AA, Hidalgo G, Quiroga A, Weng P, Sreedharan R, Selewski D, Davis K, Kallash M, Vasylyeva TL, Rheault M, Chishti A, Ranch D, Wenderfer SE, Samsonov D, Claes DJ, Akchurin O, Goumenos D, Stangou M, Nagy J, Kovacs T, Fiaccadori E, Amoroso A, Barlassina C, Cusi D, Del Vecchio L, Battaglia GG, Bodria M, Boer E, Bono L, Boscutti G, Caridi G, Lugani F, Ghiggeri G, Coppo R, Peruzzi L, Esposito V, Esposito C, Feriozzi S, Polci R, Frasca G, Galliani M, Garozzo M, Mitrotti A, Gesualdo L, Granata S, Zaza G, Londrino F, Magistroni R, Pisani I, Magnano A, Marcantoni C, Messa P, Mignani R, Pani A, Ponticelli C, Roccatello D, Salvadori M, Salvi E, Santoro D, Gembillo G, Savoldi S, Spotti D, Zamboli P, Izzi C, Alberici F, Delbarba E, Florczak M, Krata N, Mucha K, Pączek L, Niemczyk S, Mosz… See abstract for full author list ➔ Kiryluk K, et al. Among authors: park jh. Nat Genet. 2023 Jul;55(7):1091-1105. doi: 10.1038/s41588-023-01422-x. Epub 2023 Jun 19. Nat Genet. 2023. PMID: 37337107
Cooperative CAR targeting to selectively eliminate AML and minimize escape.
Haubner S, Mansilla-Soto J, Nataraj S, Kogel F, Chang Q, de Stanchina E, Lopez M, Ng MR, Fraser K, Subklewe M, Park JH, Wang X, Rivière I, Sadelain M. Haubner S, et al. Among authors: park jh. Cancer Cell. 2023 Nov 13;41(11):1871-1891.e6. doi: 10.1016/j.ccell.2023.09.010. Epub 2023 Oct 5. Cancer Cell. 2023. PMID: 37802054 Free article.
Excellence in orthodontic finishing.
Park JH. Park JH. Am J Orthod Dentofacial Orthop. 2023 Dec;164(6):761-762. doi: 10.1016/j.ajodo.2023.09.007. Am J Orthod Dentofacial Orthop. 2023. PMID: 38008489 No abstract available.
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
Park JH, Nath K, Devlin SM, Sauter CS, Palomba ML, Shah G, Dahi P, Lin RJ, Scordo M, Perales MA, Shouval R, Tomas AA, Cathcart E, Mead E, Santomasso B, Holodny A, Brentjens RJ, Riviere I, Sadelain M. Park JH, et al. Nat Med. 2023 Jul;29(7):1710-1717. doi: 10.1038/s41591-023-02404-6. Epub 2023 Jul 3. Nat Med. 2023. PMID: 37400640 Clinical Trial.
A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04).
Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, Kim SW, Kim IH, Lee S, Kim YJ, Park JH, Park SG, Lee KH, Kang EJ, Kim JW, Shin SH, Ock CY, Nam BH, Lee J, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ. Park S, et al. Among authors: park jh. J Clin Oncol. 2023 Oct 20:101200JCO2301891. doi: 10.1200/JCO.23.01891. Online ahead of print. J Clin Oncol. 2023. PMID: 37861993
Markers and makers of NKT17 cells.
Liman N, Park JH. Liman N, et al. Among authors: park jh. Exp Mol Med. 2023 Jun;55(6):1090-1098. doi: 10.1038/s12276-023-01015-y. Epub 2023 Jun 1. Exp Mol Med. 2023. PMID: 37258582 Free PMC article. Review.
GABAergic-like dopamine synapses in the brain.
Kim HJ, Hwang B, Reva M, Lee J, Lee BE, Lee Y, Cho EJ, Jeong M, Lee SE, Myung K, Baik JH, Park JH, Kim JI. Kim HJ, et al. Among authors: park jh. Cell Rep. 2023 Oct 31;42(10):113239. doi: 10.1016/j.celrep.2023.113239. Epub 2023 Oct 17. Cell Rep. 2023. PMID: 37819757 Free article.
Reply to G. Wang et al.
Park JH, Hong JY, Han K. Park JH, et al. J Clin Oncol. 2023 Nov 10;41(32):5070-5071. doi: 10.1200/JCO.23.01420. Epub 2023 Aug 21. J Clin Oncol. 2023. PMID: 37603826 No abstract available.
14,298 results
You have reached the last available page of results. Please see the User Guide for more information.